INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

People assigned to a diet, food or program and measured.

308 studies · page 2 of 13

2020 / Randomized, double-blind pilot trial

Melissa officinalis and Lavandula angustifolia showed effects similar to fluoxetine in treating mild to moderate depression over 8 weeks.

An 8-week double-blind randomized clinical trial compared Melissa officinalis (2 g/day), Lavandula angustifolia (2 g/day), and fluoxetine (20 mg/day) in 45 adult outpatients with mild to moderate major depression. Outcomes were measured at weeks 0, 2, 4, and 8 using the 17-item HAM-D. The study found that M. officinalis and L. angustifolia had an effect similar to fluoxetine (F = 0.131, df = 2,42, p = 0.877). A notable limitation stated by the authors was the absence of a placebo group.

Araj-Khodaei M, Noorbala AA, Yarani R, et al. BMC Complement Med Ther, 2020. PMID 32620104

2020 / Randomized double-blind placebo-controlled trial

Cinnamon supplementation significantly reduced migraine attack frequency, severity, duration, and inflammatory markers (IL-6 and NO) in migraine patients.

Fifty patients with migraine were randomized to receive either cinnamon powder (three capsules/day, each containing 600 mg) or placebo (three capsules/day of corn starch) for 2 months. Compared with the control group, serum concentrations of IL-6 and NO were significantly reduced in the cinnamon group (p < .05), while CGRP levels remained unchanged in both groups. In addition, the frequency, severity, and duration of migraine attacks significantly decreased in the cinnamon group compared to controls.

Zareie A, Sahebkar A, Khorvash F, et al. Phytother Res, 2020. PMID 32638445

2020 / Randomized controlled trial (2 x 2 factorial)

Long-term vitamin D3 supplementation did not reduce the risk of depression or improve mood scores in adults aged 50 or older.

In the VITAL-DEP randomized clinical trial, 18,353 participants aged 50 years or older were assigned to vitamin D3 (2000 IU/d) or placebo for a median duration of 5.3 years. Risk of depression or clinically relevant depressive symptoms did not significantly differ between the vitamin D3 group (12.9/1000 person-years) and placebo (13.3/1000 person-years; HR 0.97, 95% CI 0.87 to 1.09; P = .62). There were also no significant differences in depression incidence, recurrence, or change in PHQ-8 mood scores over time (mean difference 0.01 points, 95% CI -0.04 to 0.05 points).

Okereke OI, Reynolds CF, Mischoulon D, et al. JAMA, 2020. PMID 32749491

2020 / Randomized controlled trial

An 8-week high-polyphenol diet reduced depressive symptoms and improved mental and physical health scores in mildly hypertensive adults.

Ninety-nine mildly hypertensive participants aged 40-65 years completed a 4-week low-polyphenol diet (LPD) washout and were then randomized to either an LPD or a high-polyphenol diet (HPD) for 8 weeks. Participants in the HPD group reported a decrease in depressive symptoms on the Beck Depression Inventory-II, alongside improved physical and mental health component scores on the 36-Item Short Form Survey. No differences were observed for anxiety, stress, self-esteem, or body image perception.

Kontogianni MD, Vijayakumar A, Rooney C, et al. Nutrients, 2020. PMID 32823886

2020 / Randomized, double-blinded, placebo-controlled clinical trial

Supplementation with vitamin D3 or vitamin D-enriched mushrooms showed no significant effect on cognitive function or mood in healthy older adults.

A 6-month trial examined the effects of vitamin D3, enhanced vitamin D2 in a mushroom matrix, standard mushroom, and placebo in 436 healthy adults aged ≥60 years. Total 25-OH-D and 25-OH-D3 levels were maintained in the vitamin D3 arm but decreased significantly (p < 0.05) in the other three arms. There were no significant effects of treatment on any measures of cognitive function or mood over 24 weeks.

Zajac IT, Barnes M, Cavuoto P, et al. Nutrients, 2020. PMID 33339304

2019 / Randomized controlled trial

A Mediterranean-style diet supplemented with fish oil improved diet quality, reduced depression, and improved mental health quality of life in adults with depression.

Adults with self-reported depression were randomized to either a Mediterranean diet intervention (fortnightly food hampers, cooking workshops for 3 months, and fish oil for 6 months) or social groups fortnightly for 3 months. At 3 months, the MedDiet group showed a higher MedDiet score (t = 3.95, P < 0.01), greater reduction in depression (t = -2.24, P = 0.03), and improved mental health QoL (t = 2.10, P = 0.04), with benefits sustained at 6 months. Reduced depression correlated with higher MedDiet score (r = -0.298, P = 0.01), nuts (r = -0.264, P = 0.01), and vegetable diversity (r = -0.303, P = 0.01). Some correlations were also found between increased omega-3, decreased omega-6, and improved mental health.

Parletta N, Zarnowiecki D, Cho J, et al. Nutr Neurosci, 2019. PMID 29215971

2019 / Randomized controlled trial

Intragastric quinine decreased ghrelin, motilin, prospective food consumption, and hedonic food intake in healthy women.

In 15 healthy women, brain responses to intragastric quinine-hydrochloride (10 µmol/kg) or placebo infusion were recorded using fMRI alongside appetite-related sensations, gastrointestinal hormones, and hedonic food intake. Quinine administration lowered octanoylated ghrelin (P<0.04), total ghrelin (P<0.01), and motilin (P<0.01) plasma levels, alongside lower prospective food consumption ratings (P<0.02) and hedonic food intake (P<0.05). Quinine also increased neural activity in the hypothalamus and hedonic brain regions but decreased activity in the homeostatic medulla (all pFWE-corrected<0.05).

Iven J, Biesiekierski JR, Zhao D, et al. Nutr Neurosci, 2019. PMID 29607741

2019 / Randomized, placebo-controlled, double-blind trial

Soymilk ingestion immediately after exercise enhanced grip strength, walking speed, and endurance in chronic stroke patients.

Twenty-two chronic stroke patients underwent an 8-week rehabilitation exercise intervention (3 sessions/week, 120 min/session) and were randomly assigned to ingest either soymilk (n=11) or a placebo beverage (n=11) immediately post-exercise. Compared with placebo, immediate soymilk ingestion significantly improved hand grip strength (p=0.021), 8-feet walking speed (p=0.019), walking performance per unit lean mass (p=0.024), and 6-minute walk performance (p=0.016). However, changes in lean mass and the total score for the short physical performance battery (SPPB) did not differ between the groups.

Liao YH, Chen CN, Hu CY, et al. NeuroRehabilitation, 2019. PMID 30856124

2019 / Two-year follow-up of an open-label clinical trial

Two years after Microbiota Transfer Therapy, participants with ASD maintained GI improvements, showed further autism symptom gains, and sustained gut changes.

Researchers conducted a two-year follow-up of 18 participants with Autism Spectrum Disorders who previously completed an open-label trial of Microbiota Transfer Therapy (MTT) combining antibiotics, bowel cleanse, acid suppressant, and fecal microbiota transplant. Most improvements in gastrointestinal symptoms were maintained, and autism-related symptoms improved further two years after treatment ended. Important gut microbiota changes persisted, including significant increases in bacterial diversity and relative abundances of Bifidobacteria and Prevotella.

Kang DW, Adams JB, Coleman DM, et al. Sci Rep, 2019. PMID 30967657

2019 / Randomized, double-blind, placebo-controlled parallel-group comparative study

Oral intake of Hericium erinaceus supplements for 12 weeks significantly improved MMSE cognitive function scores.

A randomized, double-blind, placebo-controlled parallel-group comparative study evaluated the effect of Hericium erinaceus fruiting body supplements taken for 12 weeks on cognitive functions. Cognitive performance was assessed using the Mini Mental State Examination (MMSE), Benton visual retention test, and Standard verbal paired-associate learning test (S-PA). MMSE alone showed that oral intake of H. erinaceus significantly improved cognitive functions and prevented deterioration.

Saitsu Y, Nishide A, Kikushima K, et al. Biomed Res, 2019. PMID 31413233

2019 / Mixed-methods comparative study

Walking outdoors provided greater attention restoration and psychological benefits than outdoor golf in a small comparative study.

A mixed-methods study compared psychological responses between two forms of green exercise: golf and walking, in 20 participants (10 per group). Participants in the walking group exhibited significantly greater levels of dissociative cognitions and were the only group to show significant improvements in a directed attention test. The walking group also demonstrated increases in all four subscales of the Exercise-Induced Feeling Inventory, while the golf group showed no significant improvements. Qualitative findings revealed golfers viewed natural elements as obstacles, whereas walkers perceived natural stimuli as evoking positive feelings.

Fraser M, Munoz SA, MacRury S Int J Environ Res Public Health, 2019. PMID 31434352

2018 / Controlled trial

A 72-hour fast in healthy women increased mood scores and induced region-dependent reductions in brain metabolites, most notably Glx in the frontal lobes.

Fifteen healthy females were evaluated for mood, cognition, and whole-brain MR spectroscopic imaging before and after 72 hours of fasting, and compared with 15 age-matched non-fasting females. After fasting, mood scores significantly increased. Glx decreased across all nine brain regions examined, tCho decreased in eight, NAA in four, and tCr in one, with Glx showing the greatest change and the frontal lobes being the most affected brain region.

Ding XQ, Maudsley AA, Schweiger U, et al. J Cereb Blood Flow Metab, 2018. PMID 28273723

2018 / Randomized controlled trial

Daily blueberry consumption improved select cognitive measures in older adults over ninety days

In a randomized controlled trial of 37 adults aged 60 to 75 years, consuming 24 g/day of freeze-dried blueberry for 90 days improved executive function markers compared to placebo. Participants receiving blueberry showed fewer verbal learning repetition errors (p = 0.031) and reduced switch cost on task switching (p = 0.033). However, the intervention produced no changes in gait or balance performance.

Miller MG, Hamilton DA, Joseph JA, et al. Eur J Nutr, 2018. PMID 28283823

2018 / Double-blind randomized controlled trial

Vitamin D supplementation significantly improved sleep score and quality compared to placebo in adults with sleep disorders.

A double-blind clinical trial evaluated the effect of vitamin D supplementation on sleep in 89 participants aged 20-50 years with sleep disorders (44 in the intervention group and 45 in the placebo group). The intervention group received a 50,000-unit vitamin D supplement once every two weeks for 8 weeks, while the control group received a placebo. At the end of the study, the sleep score (PSQI) was significantly reduced in vitamin D recipients compared with placebo recipients (P < 0.05), even after adjusting for confounding variables (P < 0.05).

Majid MS, Ahmad HS, Bizhan H, et al. Nutr Neurosci, 2018. PMID 28475473

2018 / Randomized controlled trial

Strength training showed no significant between-group difference compared to ergonomic/posture correction for tension-type headache frequency or duration.

Sixty patients with tension-type headache were randomized to 10 weeks of strength training with elastic resistance bands or a control group receiving ergonomic and posture correction, with follow-up at 19-22 weeks. No between-group effect was detected. Within groups, the strength training group saw headache frequency decrease by 11% (P = 0.041) and duration by 10% (P = 0.036), while the control group showed reductions of 24% (P = 0.0033) and 27% (P = 0.041), respectively. The authors concluded that within-group effects did not reach clinical significance.

Madsen BK, Søgaard K, Andersen LL, et al. Cephalalgia, 2018. PMID 28750588

2018 / Randomized crossover trial

Two days of total fasting increased stress markers without altering cognitive performance.

Eleven overweight young women completed 2 days of zero-calorie fasting and 2 days of their usual diet in random order. Fasting decreased log-transformed high-frequency power, indicating higher sympathetic activity, without altering heart rate. Fasting did not change mood, prefrontal cortex activity, or cognitive, motor, or psychomotor performance.

Solianik R, Sujeta A Behav Brain Res, 2018. PMID 29097329

2018 / Double-blind, placebo-controlled randomized trial

Daily bioavailable curcumin for 18 months improved memory and attention and reduced amygdala FDDNP binding in non-demented adults.

Forty non-demented adults aged 51-84 were randomized to receive 90 mg curcumin twice daily as Theracurmin (N=21) or placebo (N=19) for 18 months. Curcumin improved verbal memory (SRT Consistent Long-Term Retrieval: ES=0.63, p=0.002; between-group ES=0.68, p=0.05), visual memory (BVMT-R Recall: ES=0.50, p=0.01; BVMT-R Delay: ES=0.51, p=0.006), and attention (ES=0.96, p<0.0001; between-group ES=0.67, p=0.04). FDDNP-PET binding decreased in the amygdala with curcumin (ES=-0.41, p=0.04; between-group ES=0.48, p=0.07) and remained unchanged in the hypothalamus with curcumin while increasing with placebo (between-group ES=0.55, p=0.02).

Small GW, Siddarth P, Li Z, et al. Am J Geriatr Psychiatry, 2018. PMID 29246725

2018 / 16-week randomized crossover noninferiority pilot study

In advanced Parkinson's disease, Mucuna pruriens showed similar efficacy to levodopa/carbidopa when tolerated, but half of patients discontinued due to side effects.

Fourteen Parkinson's disease patients with motor fluctuations and dyskinesias received Mucuna pruriens (MP) powder and levodopa/carbidopa (LD/CD) in a randomized crossover design over 16 weeks. Seven patients (50%) discontinued MP prematurely due to gastrointestinal side effects (n=4) or progressive worsening of motor performance (n=3), whereas no patients discontinued during the LD/CD phase. In patients who tolerated MP, the clinical response was similar to LD/CD across all efficacy outcomes. Dropouts later tolerated an MP supernatant water formulation in a study extension (median 16 weeks).

Cilia R, Laguna J, Cassani E, et al. Parkinsonism Relat Disord, 2018. PMID 29352722

2018 / Interventional crossover study

One night of sleep deprivation led to a significant increase in β-amyloid burden in the right hippocampus and thalamus of healthy adults.

PET and 18F-florbetaben were used to measure brain β-amyloid burden (ABB) in 20 healthy controls after a night of rested sleep and after a night of sleep deprivation. One night of sleep deprivation significantly increased ABB in the right hippocampus and thalamus compared with baseline. These increases correlated with mood worsening after sleep deprivation but were not related to APOE genotype. Baseline ABB across subcortical regions and the precuneus was inversely associated with reported night sleep hours.

Shokri-Kojori E, Wang GJ, Wiers CE, et al. Proc Natl Acad Sci U S A, 2018. PMID 29632177

2018 / Multicentre pragmatic randomized controlled trial

Moderate to high intensity exercise did not slow cognitive impairment in people with mild to moderate dementia.

A pragmatic randomized trial assigned 494 people with dementia to four months of supervised aerobic and strength exercise plus usual care (n=329) or usual care alone (n=165). At 12 months, the mean ADAS-cog score was 25.2 in the exercise group versus 23.8 in usual care (adjusted difference -1.4, 95% CI -2.6 to -0.2, P=0.03), indicating greater cognitive impairment in the exercise arm, though the clinical relevance is uncertain. No differences were detected in secondary outcomes, including activities of daily living, neuropsychiatric symptoms, or quality of life, despite improved six-minute walking distance in the exercise group (mean change 18.1 m, 95% CI 11.6 to 24.6 m).

Lamb SE, Sheehan B, Atherton N, et al. BMJ, 2018. PMID 29769247

2018 / Crossover trial

Listening to self-selected music reduced perceived exertion during moderate exercise without diminishing post-exercise gains in inhibitory control.

Fifteen healthy young men completed 30 minutes of cycle ergometer exercise at 60% of VO2 peak with either self-selected music or no music. Rate of perceived exertion right before completing exercise was significantly lower in the music condition compared to the non-music condition. Inhibitory control measured via the Stroop task significantly improved immediately after exercise and during the 30-minute recovery period in both conditions, with no significant difference between the music and non-music conditions.

Tanaka D, Tsukamoto H, Suga T, et al. Physiol Behav, 2018. PMID 29807054

2018 / Randomized crossover trial

A 2-day very low-calorie diet in obese young women evoked moderate stress, altered specific cognitive functions, and did not affect autonomic function or mood.

Nine obese women aged 22-31 years were tested under two randomly allocated conditions: a 2-day very low-calorie diet (511 kcal) and a 2-day usual diet. The calorie-restricted diet received a subjective stress rating of 41.5 ± 23.3, but had no detectable effects on heart rate variability indices, mood, grip strength, or psychomotor functions. However, calorie restriction significantly increased spatial processing and visuospatial working memory accuracy (p < 0.05) and decreased cognitive flexibility accuracy (p < 0.05).

Solianik R, Sujeta A, Čekanauskaitė A Exp Brain Res, 2018. PMID 29860630

2018 / Prospective single-arm study

A 6-month ketogenic diet reduced gut microbiome alpha diversity and altered bacterial composition in children with refractory epilepsy.

Twenty children with refractory epilepsy were prospectively evaluated before and 6 months after starting a ketogenic diet. Following 6 months of therapy, 2 patients became seizure-free, 3 achieved a ≥ 90% reduction, 5 had a 50-89% reduction, and 10 had a < 50% reduction, with all 10 responders showing EEG improvements. Fecal microbial profiles demonstrated lower alpha diversity compared with baseline, along with significantly decreased Firmicutes and increased Bacteroidetes abundance. Non-responsive patients were found to have enrichment of Clostridiales, Ruminococcaceae, Rikenellaceae, Lachnospiraceae, and Alistipes.

Zhang Y, Zhou S, Zhou Y, et al. Epilepsy Res, 2018. PMID 30007242

2018 / Randomized controlled trial

Lettuce seed supplementation improved sleep quality scores in pregnant women with insomnia.

One hundred pregnant women with insomnia were randomized to receive 1,000 mg of lettuce seed capsules or a placebo daily for 2 weeks. Sleep quality improved significantly more in the lettuce seed group than in the placebo group as measured by the Pittsburgh Sleep Quality Index. After controlling for other variables, the experimental group had significantly lower average sleep scores (p = 0.03).

Pour ZS, Hosseinkhani A, Asadi N, et al. J Ethnopharmacol, 2018. PMID 30172900